User profiles for "author:Mirjam R Heldner"

Mirjam R Heldner

University Hospital and University of Bern
Verified email at insel.ch
Cited by 5210

European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic …

J Dawson, Y Béjot, LM Christensen… - European stroke …, 2022 - journals.sagepub.com
Recurrent stroke affects 9% to 15% of people within 1 year. This European Stroke
Organisation (ESO) guideline provides evidence-based recommendations on …

[HTML][HTML] Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission

VL Feigin, MO Owolabi, F Abd-Allah… - The Lancet …, 2023 - thelancet.com
Executive summary Stroke is the second leading cause of death worldwide. The burden of
disability after a stroke is also large, and is increasing at a faster pace in low-income and …

Systematic review and meta-analysis on outcome differences among patients with TICI2b versus TICI3 reperfusions: success revisited

J Kaesmacher, T Dobrocky, MR Heldner… - Journal of Neurology …, 2018 - jnnp.bmj.com
Objective A reperfusion quality of thrombolysis in cerebral infarction (TICI)≥ 2b has been set
as the therapeutic angiography target for interventions in patients with acute ischaemic …

National Institutes of Health stroke scale score and vessel occlusion in 2152 patients with acute ischemic stroke

MR Heldner, C Zubler, HP Mattle, G Schroth, A Weck… - Stroke, 2013 - Am Heart Assoc
Background and Purpose—There is some controversy on the association of the National
Institutes of Health Stroke Scale (NIHSS) score to predict arterial occlusion on MR …

Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia

MS Van Kammen, DA De Sousa, S Poli… - JAMA …, 2021 - jamanetwork.com
Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and …

Factors that determine penumbral tissue loss in acute ischaemic stroke

S Jung, M Gilgen, J Slotboom, M El-Koussy, C Zubler… - Brain, 2013 - academic.oup.com
The goal of acute stroke treatment with intravenous thrombolysis or endovascular
recanalization techniques is to rescue the penumbral tissue. Therefore, knowing the factors …

Safety of thrombolysis in stroke mimics: results from a multicenter cohort study

SM Zinkstok, ST Engelter, H Gensicke, PA Lyrer… - Stroke, 2013 - Am Heart Assoc
Background and Purpose—Intravenous thrombolysis for acute ischemic stroke is beneficial
within 4.5 hours of symptom onset, but the effect rapidly decreases over time, necessitating …

Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency

K Krzywicka, MR Heldner… - European journal of …, 2021 - Wiley Online Library
Background and purpose Cerebral venous sinus thrombosis (CVST) has been described
after vaccination against SARS‐CoV‐2. The clinical characteristics of 213 post‐vaccination …

Prior anticoagulation in patients with ischemic stroke and atrial fibrillation

TR Meinel, M Branca, GM De Marchis… - Annals of …, 2021 - Wiley Online Library
Objective The aim was to evaluate, in patients with atrial fibrillation (AF) and acute ischemic
stroke, the association of prior anticoagulation with vitamin K antagonists (VKAs) or direct …

Prediction of early neurological deterioration in individuals with minor stroke and large vessel occlusion intended for intravenous thrombolysis alone

P Seners, WB Hassen, B Lapergue, C Arquizan… - JAMA …, 2021 - jamanetwork.com
Importance The best reperfusion strategy in patients with acute minor stroke and large
vessel occlusion (LVO) is unknown. Accurately predicting early neurological deterioration of …